From 2000-2009 he was Editor-in-Chief of the Journal of Substance Abuse Treatment. From 2009 to 2011, he was Deputy Director of the White House Office of National Drug Control Policy (ONDCP) where he formulated President Obama’s National Drug Control Strategy and helped include addiction treatment into the Affordable Care Act. In 2015-2016 he served as Senior Editor on the US Surgeon General’s Report, Facing Addiction.
In his career he has published over 550 articles and chapters on addiction research and was awarded over 150 NIH research grants. He has been among the top ten most cited researchers in the addiction field for 15 years.
Dr. McLellan is the recipient of several distinguished awards including the Lifetime Achievement Awards of the American, Italian, Australian, Egyptian and British Societies of Addiction Medicine; the Robert Wood Johnson Innovator Award; Distinguished Contribution to Addiction Medicine from the American Public Health Association, the American Medical Association; and jointly from the National Institutes of Drug Abuse and Alcoholism and Alcohol Abuse.
He currently serves on the boards of Indivior LLC (makers of Suboxone) and Recover Together; and lives with his wife Kerry in Sarasota Florida.
Pre-Addiction - A Missing Concept for Treating Substance Use Disorder, Aug 2022
Marijuana is addictive, especially with the high potency products. And with addiction come withdrawal. Withdrawal of THC is not like withdrawal from fentanyl or...
Dr. Matthew Fedoruk currently works as the Chief Science Officer leading the Science & Research team at the U.S. Anti-Doping Agency (USADA). Dr. Fedoruk...
What are some upcoming innovations for methamphetamine use disorder? Learn from Dr. Brooks Gentry how monoclonal antibodies can be the new MAT for meth....
